The National Disease Research Interchange’s (NDRI) biorepository in Philadelphia recently received accreditation from the College of American Pathologists (CAP).
The accreditation came after a recent onsite inspection as part of CAP’s accreditation programs. With this, the NDRI joins the more than 8,000 CAP-accredited biorepository facilities worldwide. The interchange was first accredited by the CAP in 2016.